Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.62 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.58 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | ALPL | P05186 | 1/20 | 0.57 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | ALPG | P10696 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | PLEC | Q15149 | 1/20 | 0.55 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | CA9 | Q16790 | 9/20 | 0.50 |
| ▸ | CA1 | P00915 | 7/20 | 0.49 |
| ▸ | CA2 | P00918 | 7/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.47 |
| ▸ | HTRA2 | O43464 | 1/20 | 0.46 |
| ▸ | HTRA1 | Q92743 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19543669 | 0.93 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| 6-Carboxyfluorescein SCHEMBL29369299 | 0.90 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| 6-Carboxyfluorescein SCHEMBL9906208 | 0.90 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12061907 | 0.89 | USP2 (0.66) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL13497987 | 0.87 | USP2 (0.59) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL12604830 | 0.87 | USP2 (0.69) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL14642481 | 0.86 | USP2 (0.62) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL13785142 | 0.86 | DNASE1L3 (0.63) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL13401323 | 0.86 | USP2 (0.62) | USP2L3MBTL1DNASE1L3PRMT1MEN1 | |
| SCHEMBL16231516 | 0.86 | USP2 (0.64) | USP2L3MBTL1DNASE1L3PRMT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012304-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | Sony Group Corporation (JP) | 2023-01-12 | — | — | US | disclosed |
| US-11312736-B1 | Programmable polymeric drugs | SONY CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| US-10041115-B2 | 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing | LASERGEN, INC. (US) | 2018-08-07 | — | — | US | disclosed |
| US-20170327886-A1 | 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING | LASERGEN, INC. (US) | 2017-11-16 | — | — | US | disclosed |
| US-20090111100-A1 | MINOR GROOVE BINDER - ENERGY TRANSFER OLIGONUCLEOTIDES AND METHODS FOR THEIR USE | ELITECH HOLDING B.V. (NL) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11312736-B1 | Programmable polymeric drugs | NCL, PBRM1, LPXN | USP2 2142/4885L3MBTL1 81/4885DNASE1L3 446/4885 |
| US-20090111100-A1 | MINOR GROOVE BINDER - ENERGY TRANSFER OLIGONUCLEOTIDES AND METHODS FOR THEIR USE | SSBP1, SNRPE, TARBP1 | USP2 4870/4885L3MBTL1 223/4885DNASE1L3 517/4885 |
| US-10041115-B2 | 3′-OH unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing | RNGTT, NT5C3B, NSUN2 | USP2 1610/4885L3MBTL1 205/4885DNASE1L3 176/4885 |
| US-20170327886-A1 | 3'-OH UNBLOCKED, FAST PHOTOCLEAVABLE TERMINATING NUCLEOTIDES AND METHODS FOR NUCLEIC ACID SEQUENCING | RNGTT, NT5C3B, NSUN2 | USP2 1587/4885L3MBTL1 196/4885DNASE1L3 170/4885 |
| US-20230012304-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, MTCL3, TMT1A | USP2 2719/4885L3MBTL1 22/4885DNASE1L3 2554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.